High‐Frequency, At‐Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID ‐19 Treatment is a research paper published in Clinical and Translational Science (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1UL1TR002345-01
Washington University Institute of Clinical and Translational Sciences
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals